Clinical Trial Update: Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating metformin in combination with standard induction therapy for diffuse large B-cell lymphoma was terminated; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Rush University Medical Center | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-01-27